Race Oncology Ltd (ASX:RAC) has been granted a trading halt by the ASX, pending details of a joint venture.
The company recently secured an agreement with the National Cancer Institute (NCI) in the United States.
The halt will remain in place until the opening of trade on Tuesday 11th July 2017, or earlier if an announcement is made to the market.